Endothelium-Independent Effect of Fisetin on the Agonist-Induced Regulation of Vascular Contractility
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Je, Hyun Dong | - |
dc.contributor.author | Sohn, Uy Dong | - |
dc.contributor.author | La, Hyen-Oh | - |
dc.date.available | 2019-03-08T13:56:03Z | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.issn | 2005-4483 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/7393 | - |
dc.description.abstract | Fisetin, a natural flavonoid found in a variety of vegetables and fruits, has been shown to possess many biological functions. The present study was undertaken to investigate the influence of fisetin on vascular smooth muscle contractility and to determine the mechanism involved. Denuded aortic rings from male rats were used and isometric contractions were recorded and combined with molecular experiments. Fisetin significantly relaxed fluoride-, thromboxane A(2)- or phorbol ester-induced vascular contraction suggesting as a possible anti-hypertensive on the agonist-induced vascular contraction regardless of endothelial nitric oxide synthesis. Furthermore, fisetin significantly inhibited fluoride-induced increases in pMYPT1 levels and phorbol ester-induced increases in pERK1/2 levels suggesting the mechanism involving the inhibition of Rho-kinase activity and the subsequent phosphorylation of MYPT1 and MEK activity and the subsequent phosphorylation of ERK1/2. This study provides evidence regarding the mechanism underlying the relaxation effect of fisetin on agonist-induced vascular contraction regardless of endothelial function. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
dc.title | Endothelium-Independent Effect of Fisetin on the Agonist-Induced Regulation of Vascular Contractility | - |
dc.type | Article | - |
dc.identifier.doi | 10.4062/biomolther.2015.104 | - |
dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.24, no.1, pp 57 - 61 | - |
dc.identifier.kciid | ART002060562 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000367640100008 | - |
dc.identifier.scopusid | 2-s2.0-84952705454 | - |
dc.citation.endPage | 61 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 57 | - |
dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.volume | 24 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | ERK1/2 | - |
dc.subject.keywordAuthor | Fisetin | - |
dc.subject.keywordAuthor | Fluoride | - |
dc.subject.keywordAuthor | MYPT1 | - |
dc.subject.keywordAuthor | Phorbol ester | - |
dc.subject.keywordAuthor | Rho-kinase | - |
dc.subject.keywordPlus | SMOOTH-MUSCLE CONTRACTION | - |
dc.subject.keywordPlus | RHO-KINASE | - |
dc.subject.keywordPlus | MEDIATED INHIBITION | - |
dc.subject.keywordPlus | MYOSIN PHOSPHATASE | - |
dc.subject.keywordPlus | THORACIC AORTA | - |
dc.subject.keywordPlus | PROTEIN-KINASE | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | PHOSPHORYLATION | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.